ConductScience.org, home

Paper40564985

Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology.

Jannati S and 3 others. Int J Mol Sci, 2025. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology. Papers, record 40564985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40564985

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Oleocanthal as a Multifunctional Anti-Cancer Agent: Mechanistic Insights, Advanced Delivery Strategies, and Synergies for Precision Oncology.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
6.07, provisional
iCite
Revised in PubMed
2026-09-24
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jannati SShirin
2Patel AAdibahttps://orcid.org/0009-0005-1326-2960
3Patnaik RRajashree
4Banerjee YYajnavalkahttps://orcid.org/0000-0002-7546-8893

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
NeoplasmsMajor topic
Cyclopentane MonoterpenesMajor topic
AldehydesMajor topic
Humans
Precision Medicine
Animals
Drug Delivery Systems
Phenols

Source PubMed

Download CSV of topics

References217

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134063828Inflammation-Induced Tumorigenesis and Metastasis.Int J Mol Sci2021https://conductscience.org/library/papers/34063828PubMed
215066921Dietary patterns and risk of breast cancer in the ORDET cohort.Cancer Epidemiol Biomarkers Prev2004https://conductscience.org/library/papers/15066921PubMed
320947337Consumption of animal products, olive oil and dietary fat and results from the Belgian case-control study on bladder cancer risk.Eur J Cancer2011https://conductscience.org/library/papers/20947337PubMed
410645813Prostate cancer and dietary carotenoids.Am J Epidemiol2000https://conductscience.org/library/papers/10645813PubMed
516512965Olive oil consumption and risk of breast cancer in the Canary Islands: a population-based case-control study.Public Health Nutr2006https://conductscience.org/library/papers/16512965PubMed
638136231Oleocanthal, an Antioxidant Phenolic Compound in Extra Virgin Olive Oil (EVOO): A Comprehensive Systematic Review of Its Potential in Inflammation and Cancer.Antioxidants (Basel)2023https://conductscience.org/library/papers/38136231PubMed
734088913Protein suppresses both bitterness and oleocanthal-elicited pungency of extra virgin olive oil.Sci Rep2021https://conductscience.org/library/papers/34088913PubMed
823584393Extracellular vesicles: biology and emerging therapeutic opportunities.Nat Rev Drug Discov2013https://conductscience.org/library/papers/23584393PubMed
937910854Pharmacokinetics and Metabolism Investigation of Oleocanthal.J Nat Prod2024https://conductscience.org/library/papers/37910854PubMed
1038254699A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment.Biomolecules2024https://conductscience.org/library/papers/38254699PubMed
1136771326S-(-)-Oleocanthal Ex Vivo Modulatory Effects on Gut Microbiota.Nutrients2023https://conductscience.org/library/papers/36771326PubMed
1239806451Emerging role of exosomes in cancer therapy: progress and challenges.Mol Cancer2025https://conductscience.org/library/papers/39806451PubMed
1339064815Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers.Nutrients2024https://conductscience.org/library/papers/39064815PubMed
1425037503The pentose phosphate pathway and cancer.Trends Biochem Sci2014https://conductscience.org/library/papers/25037503PubMed
1526244666Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status.PLoS One2015https://conductscience.org/library/papers/26244666PubMed
1634445193Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis.Int J Mol Sci2021https://conductscience.org/library/papers/34445193PubMed
1739200224The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases.Biomedicines2024https://conductscience.org/library/papers/39200224PubMed
1836139600Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer.Cancers (Basel)2022https://conductscience.org/library/papers/36139600PubMed
1935912181Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer.Front Oncol2022https://conductscience.org/library/papers/35912181PubMed
2037131291Crohn's disease proteolytic microbiota enhances inflammation through PAR2 pathway in gnotobiotic mice.Gut Microbes2023https://conductscience.org/library/papers/37131291PubMed

See all 217 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42738930Time-Dependent Multimechanistic Antitumor Effects of Olive Oil Phenolics in a Triple-Negative Breast Cancer Mouse Model.Nutrients2026https://conductscience.org/library/papers/42738930PubMed
42737430Protease-Activated Receptor-2 as a Proteolytic Rheostat in Colorectal and Pancreatic Cancer: From Mechanism to Biomarker-Guided Therapy.Int J Mol Sci2026https://conductscience.org/library/papers/42737430PubMed
42654203Lead Validation of the Olive Phenolic S-(-)-Oleocanthal for Effective Control of KRASG13D-Mutant Colorectal Cancer Progression and Metastasis.Nutrients2026https://conductscience.org/library/papers/42654203PubMed
42589399Rosmarinic Acid Sensitizes Ovarian Cancer Cells to Gemcitabine Through Oxidative Stress-Associated Apoptotic and Antiproliferative Responses.Int J Mol Sci2026https://conductscience.org/library/papers/42589399PubMed
42588034Nutraceuticals in Uro-Oncology: A Structured Expert Review and Precision-Oriented Framework.Nutrients2026https://conductscience.org/library/papers/42588034PubMed
42583093
Exploring the molecular basis of Panax notoginseng mediated inhibition of cervical cancer through machine learning, transcriptomics analysis, network pharmacology, molecular docking, and in-silico simulation approaches.
Bioinform Adv2026https://conductscience.org/library/papers/42583093PubMed
42301532Programmed cell death and metastatic evolution in breast cancer: the role of anoikis, necroptosis, and ferroptosis.Apoptosis2026https://conductscience.org/library/papers/42301532PubMed
42072053Oleocanthal Induces Mitochondrial Dysfunction in Breast Cancer Cell Lines Depending on c-MET Expression.Antioxidants (Basel)2026https://conductscience.org/library/papers/42072053PubMed
42053656Immunotherapy for depression: targeting cytokine pathways in major depressive disorder.Psychopharmacology (Berl)2026https://conductscience.org/library/papers/42053656PubMed
42004177Taoren Honghua Jian Regulate NLRP3 Inflammasome of Coronary Artery Disease Patients: A Multi-Center, Double-Blind, Randomized Controlled Trial.Vasc Health Risk Manag2026https://conductscience.org/library/papers/42004177PubMed
41832248Next generation approaches in cancer immunotherapy targeting mechanisms beyond PD1 and PDL1.Discov Oncol2026https://conductscience.org/library/papers/41832248PubMed
41438572Oxidative stability of extra virgin olive oil assessed by electron paramagnetic resonance, chemical composition, and multivariate analysis.Curr Res Food Sci2026https://conductscience.org/library/papers/41438572PubMed
41160113GPCR Biased Signaling in Cancer.Handb Exp Pharmacol2026https://conductscience.org/library/papers/41160113PubMed
41156614In Vitro Inhibition of Cryptosporidium parvum Infection by the Olive Oil Component Oleocanthal.Pathogens2025https://conductscience.org/library/papers/41156614PubMed
41009479
In Silico and In Vitro Studies of Anti-Inflammatory, Anti-Oxidative Stress, and Anti-Apoptosis Effect of 7-Octenoic Acid Derived from Moringa oleifera Lam., on LPS-Induced Monocyte-Derived Macrophages (MDM).
Int J Mol Sci2025https://conductscience.org/library/papers/41009479PubMed
40943351Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-κB, NLRP3 Inflammasome, and Cytokine Regulatory Axes.Int J Mol Sci2025https://conductscience.org/library/papers/40943351PubMed
40807332Harnessing Nature's Chemistry: Deciphering Olive Oil Phenolics for the Control of Invasive Breast Carcinoma.Molecules2025https://conductscience.org/library/papers/40807332PubMed
40647462
Exploring Experimental Models of Colorectal Cancer: A Critical Appraisal from 2D Cell Systems to Organoids, Humanized Mouse Avatars, Organ-on-Chip, CRISPR Engineering, and AI-Driven Platforms-Challenges and Opportunities for Translational Precision Oncology.
Cancers (Basel)2025https://conductscience.org/library/papers/40647462PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40564985

GET https://conductscience.org/api/papers/v1/40564985/references?page=2